About
Associate with over ten years in biomedical research, previously a consultant at ClearView Healthcare Partners. Earned his PhD in cancer biology at the University of Chicago and interned with ARCH Venture Partners.
Experience
- Cure VenturesAssociatecurrent2024 β presentBoston, Massachusetts, United States
- ClearView Healthcare PartnersConsultant2024Boston, Massachusetts, United States
- ARCH Venture PartnersAnalyst (Part-time)2021 β 2024Chicago, Illinois, United States
- Polsky Center at the University of ChicagoInnovation Fund Associate2021Chicago, Illinois, United States
- GenentechMolecular Biology Intern2018San Francisco Bay Area
- Dana-Farber Cancer InstituteResearch Technician2016 β 2018Greater Boston Area
Education
- University of ChicagoDoctor of Philosophy - PhD, Cancer Biology2018 β 2024
- The University of Chicago Booth School of BusinessCourses taken at Booth School of Business2019 β 2023
- University of California, BerkeleyBachelor's degree, Molecular and Cell Biology
Skills & more
Research34Statistics13BioinformaticsMachine LearningData VisualizationLeadership16R1SQLLinuxPython (Programming Language)
Languages Chinese Β· English Β· German
- Advanced Learning Algorithms β Coursera
- Supervised Machine Learning: Regression and Classification β Coursera
From Weihan's professional profile.
Same school
Also attended University of Chicago242
Mark SusterManaging Partner at Upfront VenturesShardul ShahInvestor at Index VenturesSam BlackmanEntrepreneur in Residence at GV (Google Ventures)Clay FisherInvestor at Spark CapitalJonas CiplickasPrincipal at Scale Venture PartnersJulia Gonzalez SandersPartner and General Counsel at Crosslink Capital
+ 236 more
Also attended The University of Chicago Booth School of Business431
Prashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesTinaInvestments & Portfolio Services Team Member at Clear VenturesBill PescatelloInvestor at LightbankGlebFounder and Managing Partner at iTech CapitalRavi RajamonyVice President at March Capital Partners
+ 425 more
Also attended University of California, Berkeley863
Byron DeeterPartner at Bessemer Venture PartnersTrevor OelschigInvestment Team at General CatalystBrendan Bulik-SullivanInvestor at GV (Google Ventures)Glen AndersonPartner at Monta Vista CapitalAnthony LinHead of Intel Capital, Corporate Vice President at Intel CapitalScott ShawChief of Staff at Intel Capital
+ 857 more
Shared employers
Also worked at ClearView Healthcare Partners11
Matthew WongAnalyst at FusionJack WangInsights Manager at McKesson VenturesDavid PrimPrincipal at Broadview VenturesMichelle LevinePrincipal at Solasta VenturesCaroline FernerAssociate at Ajax HealthClaire Elizabeth SmithPartner at SpringTide Ventures
+ 5 more
Also worked at ARCH Venture Partners25
Steve GillisManaging Director at ARCH Venture PartnersCarol SuhPartner at ARCH Venture PartnersSean KendallPartner (Europe) at ARCH Venture PartnersCorey RitterPartner at ARCH Venture PartnersLuciana BorioVenture Partner at ARCH Venture PartnersJoseph JeongVenture Partner at ARCH Venture Partners
+ 19 more
Also worked at Polsky Center at the University of Chicago10
Saad AnsariInvestor at Dash VCRiley FriedenbergAssociate at Interlock PartnersZhou ZangSenior Associate at Corazon CapitalHemant ElhenceGeneral Partner at 3Lines Venture CapitalScott WalbrunPrincipal at BMW i VenturesIlana HabibPrincipal, Direct Investments at Cintrifuse Capital
+ 4 more
Also worked at Genentech89
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 83 more
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures














.jpeg)





























